Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2400-0.1700 (-4.99%)
At close: 04:00PM EDT
3.2800 +0.04 (+1.23%)
After hours: 07:10PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close3.4100
Open3.3600
Bid3.2000 x 1100
Ask3.2900 x 800
Day's Range2.9500 - 3.4400
52 Week Range2.9500 - 48.6000
Volume191,039
Avg. Volume91,470
Market Cap21.462M
Beta (5Y Monthly)2.23
PE Ratio (TTM)N/A
EPS (TTM)-14.8540
Earnings DateAug 04, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est40.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SRGA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Surgalign Holdings, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/16/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • GlobeNewswire

    Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

    DEERFIELD, Ill., June 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to five (5) employees, none of whom was an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 27,877 shares of Surgalign common

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split

    DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting of Stockholders (“Annual Meeting”) on May 10, 2022, the Board and stockholders of the Company approved a reverse stock split of the Company’s issued and outstanding shares of its common stock and authorized the Board to select the ratio of the

  • GlobeNewswire

    Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range

    DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 first quarter ended March 31, 2022. Financial Highlights and Key Events: Received FDA 510(k) clearance for HOLO Portal™ System, the world's first AI-driven AR guidance system for spine surgery;1st Holo Portal™ site up and running;1st succe

Advertisement
Advertisement